An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

NCT00791700 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Maraviroc

Sponsor

ViiV Healthcare

Collaborators

[object Object]